journal
MENU ▼
Read by QxMD icon Read
search

Journal of Ocular Pharmacology and Therapeutics

journal
https://www.readbyqxmd.com/read/30004830/oral-anti-vascular-endothelial-growth-factor-drugs-and-ocular-side-effects
#1
Frederick T Fraunfelder, Frederick W Fraunfelder
PURPOSE: To evaluate possible associations between oral anti-vascular endothelial growth factor (VEGF) drugs and ocular side effects. METHODS: Spontaneous reports were collected and evaluated by the National Registry of Drug-Induced Ocular Side Effects on the three oral anti-VEGF drugs (pazopanib, sorafenib, and sunitinib) for possible ocular side effects. RESULTS: Reported side effects include blurred or decreased vision (389 cases); periocular or eyelid edema (273 cases); superficial anterior segment toxicity (270 cases); conjunctival, retinal, or vitreous bleeding (77 cases); retinal detachments (RDs) or retinal tears (RTs) (75 cases); extraocular muscle disorders, including ptosis (51 cases); discoloration of eyelashes (36 cases); retinal arterial or venous occlusions (26 cases); optic nerve disorders, including papilledema and ischemic optic neuropathy (21 cases); uveitis (10 cases); and macular edema (7 cases)...
July 13, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29989843/effects-of-a-novel-selective-ep2-receptor-agonist-omidenepag-isopropyl-on-aqueous-humor-dynamics-in-laser-induced-ocular-hypertensive-monkeys
#2
Masahiro Fuwa, Carol B Toris, Shan Fan, Takazumi Taniguchi, Masaki Ichikawa, Noriko Odani-Kawabata, Ryo Iwamura, Kenji Yoneda, Takeshi Matsugi, Naveed K Shams, Jin-Zhong Zhang
PURPOSE: To investigate the mechanism of the intraocular pressure (IOP)-lowering effect of a novel selective prostaglandin E2 receptor 2 (EP2) receptor agonist, omidenepag isopropyl (OMDI). METHODS: The effect of OMDI on IOP and aqueous humor dynamics was evaluated in cynomolgus monkeys with unilateral laser-induced ocular hypertension. In a crossover manner, the hypertensive eye of each monkey was dosed once daily with 20 μL of either 0.002% OMDI or vehicle...
July 10, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29958057/efficacy-and-safety-of-loteprednol-0-5-and-fluorometholone-0-1-after-strabismus-surgery-in-children
#3
Yung Ju Yoo, Hee Kyung Yang, Jeong-Min Hwang
PURPOSE: To compare the effects of topical loteprednol and fluorometholone in children who underwent strabismus surgery. METHODS: This is a retrospective observational case series. A total of 60 Korean children who underwent strabismus surgery between January 2016 and September 2016 were included. Patients were prescribed topical loteprednol etabonate 0.5% or fluorometholone 0.1% until 3 weeks after surgery. Four parameters (intraocular pressure [IOP], conjunctival injection, conjunctival inflammation, and patient discomfort) were assessed every week for up to 4 weeks after surgery...
June 29, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29958030/suppression-of-th1-mediated-keratoconjunctivitis-sicca-by-lifitegrast
#4
Rodrigo Guimaraes de Souza, Zhiyuan Yu, Michael E Stern, Stephen C Pflugfelder, Cintia S de Paiva
PURPOSE: Increased interferon gamma (IFN-γ) expression in dry eye causes ocular surface epithelial disease termed keratoconjunctivitis sicca (KCS). The purpose of this study was to investigated the effects of the LFA-1 antagonist, lifitegrast, in a mouse desiccating stress (DS) dry eye model that develops KCS similar to Sjögren syndrome. METHODS: Mice were treated with vehicle or lifitegrast twice daily for 5 days and expression of Th1 family genes (IFN-γ, CXCL9, and CXCL11) was evaluated by real-time polymerase chain reaction...
June 29, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29927692/eyes-on-new-product-development
#5
Gary D Novack
No abstract text is available yet for this article.
June 21, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29924675/pharmacokinetic-analysis-of-intraocular-penetration-of-latanoprost-solutions-with-different-preservatives-in-human-eyes
#6
Gary D Novack
No abstract text is available yet for this article.
June 20, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29924674/quantitative-assessment-of-retina-explant-viability-in-a-porcine-ex-vivo-neuroretina-model
#7
Christina L Rettinger, Heuy-Ching Wang
PURPOSE: Given that porcine and human retinas have similar structures and characteristics, ex vivo culture of porcine neuroretina provides an attractive model for studying mechanisms of human retinal injury and degenerative disease. Here, we describe the method that was used to establish and characterize an adult porcine retina culture system as a rapid screening tool for retinal survival in real time. METHODS: Neuroretina explants 8 mm in diameter were harvested from adult swine and cultured on porous cell culture inserts with adjustable heights...
June 20, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29912609/the-poly-adp-ribose-polymerase-1-inhibitor-1-5-isoquinolinediol-attenuate-diabetes-induced-nadph-oxidase-derived-oxidative-stress-in-retina
#8
Ghulam Mohammad, Saleh Hamed Alrashed, Abdullah Ibrahim Almater, Mohammad Mairaj Siddiquei, Ahmed M Abu El-Asrar
PURPOSE: To examine the effects of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor 1,5-isoquinolinediol (IQ) on nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-derived oxidative stress in diabetic retina. METHODS: Streptozotocin-induced diabetic rats were treated with IQ. The NADPH oxidase enzyme activity was determined by luminometer. Expression of gp91phox , P47phox and nitrated proteins was examined by western blot. Interaction between gp91phox and P47phox was determined by coimmunoprecipitation...
June 18, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29792548/comparison-of-the-ocular-penetration-and-pharmacokinetics-between-natamycin-and-voriconazole-after-topical-instillation-in-rabbits
#9
Xin Zhao, Yang Tong, Xiaotong Wang, Xian Zhang, Shichao Chen, Hong Lu
PURPOSE: To investigate the ocular penetration of natamycin (NAT) and voriconazole (VRC) after topical instillation in New Zealand white rabbits using simplified liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography. METHODS: Seventy-eight healthy rabbits were randomly divided into 3 groups. In the first 2 groups, 72 rabbits were used for single-dose testing (36 for NAT, 36 for VRC), in which 50 μL of 5.0% NAT or 1...
May 24, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29782196/a-randomized-clinical-trial-of-topical-diclofenac-fluorometholone-and-dexamethasone-for-control-of-inflammation-after-strabismus-surgery
#10
Jinsoo Kim, Dong Chul Choi, Seokhyun Bae, Dong Gyu Choi, Joo Yeon Lee
PURPOSE: To evaluate the comparative effects and safety of topical diclofenac sodium, fluorometholone, and dexamethasone for controlling inflammation after routine strabismus surgery. METHODS: This was a randomized clinical trial. Ninety-nine patients admitted for surgery to treat intermittent exotropia were randomly assigned to receive 1 of 3 postoperative eye drops between January 2015 and February 2016. The primary efficacy outcomes were pain and conjunctival injection...
May 21, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29762073/the-association-of-socioeconomic-status-with-severity-of-glaucoma-and-the-impacts-of-both-factors-on-the-costs-of-glaucoma-medications-a-cross-sectional-study-in-west-bengal-india
#11
Tutul Chakravarti
PURPOSE: To evaluate the association of socioeconomic status (SES) with severity of glaucoma and assess the impacts of both SES and disease-severity factors on the costs of glaucoma medications among different glaucoma subtypes in West Bengal, India. METHODS: This cross-sectional study (2014-16) followed the treatment of 304 primary glaucoma patients for at least 18 months. The visual field based glaucoma staging was followed for stages 0-3; patients with field of vision <10° were categorized as stage 4 (end stage)...
May 15, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29708819/impact-of-flow-rate-collection-devices-and-extraction-methods-on-tear-concentrations-following-oral-administration-of-doxycycline-in-dogs-and-cats
#12
Lionel Sebbag, Lucas Showman, Emily M McDowell, Ann Perera, Jonathan P Mochel
PURPOSE: Compare the precision of doxycycline quantification in tear fluid collected with either Schirmer strips or polyvinyl acetal (PVA) sponges following oral drug administration. METHODS: Three dogs and 3 cats were administered doxycycline orally at a dose of 4.2-5 mg/kg every 12 h for 6 consecutive days. At day 5 and 6, blood and tear fluid were sampled to capture doxycycline trough and maximal concentrations. Tear fluid was collected 3 times (spaced 10 min apart) at each session with the absorbent material placed in the lower conjunctival fornix until the 20-mm mark was reached (Schirmer strip, one eye) or for 1 min (PVA sponge, other eye)...
April 30, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29708810/ocular-toxicity-profile-of-st-162-and-st-168-as-novel-bifunctional-mek-pi3k-inhibitors
#13
Andrew Smith, Mercy Pawar, Marcian E Van Dort, Stefanie Galbán, Amanda R Welton, Greg M Thurber, Brian D Ross, Cagri G Besirli
PURPOSE: ST-162 and ST-168 are small-molecule bifunctional inhibitors of MEK and PI3K signaling pathways that are being developed as novel antitumor agents. Previous small-molecule and biologic MEK inhibitors demonstrated ocular toxicity events that were dose limiting in clinical studies. We evaluated in vitro and in vivo ocular toxicity profiles of ST-162 and ST-168. METHODS: Photoreceptor cell line 661W and adult retinal pigment epithelium cell line ARPE-19 were treated with increasing concentrations of bifunctional inhibitors...
April 30, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29708803/a-5-year-follow-up-study-of-the-treatment-of-macular-edema-due-to-retinal-vein-occlusion-using-dexamethasone-intravitreal-implants
#14
Gonzaga Garay-Aramburu, Ángela Gómez-Moreno
PURPOSE: To evaluate the long-term effects of intravitreal dexamethasone implants (IDIs) in eyes with macular edema (ME) due to retinal vein occlusion (RVO). METHODS: We reviewed the records of 10 patients followed for 5 years after they received their first IDI. The main outcome measures included changes in best corrected visual acuity (BCVA), central macular thickness (CMT), and central macular volume (CMV), and the incidence of side effects. RESULTS: Ten patients were included in the study with a mean follow-up of 65...
April 30, 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29812993/effect-of-0-05-difluprednate-ophthalmic-emulsion-on-proinflammatory-cytokine-levels-after-retinal-laser-photocoagulation-in-rabbits
#15
Hiroshi Kakimoto, Yoshihiro Takamura, Shogo Arimura, Seiji Miyake, Takehiro Matsumura, Makoto Gozawa, Kentaro Iwasaki, Masakazu Morioka, Yutaka Yamada, Masaru Inatani
PURPOSE: We aimed to evaluate the effect of the topical application of a strong corticosteroid, difluprednate, on the levels of inflammatory and angiogenic cytokine in the vitreous and aqueous humor after laser photocoagulation. METHODS: Pigmented rabbits were treated with retinal laser photocoagulation and divided into 4 groups, namely control (no additional treatment), topical application of difluprednate 0.05%, betamethasone sodium phosphate 0.1%, and sub-Tenon injection of triamcinolone acetonide (STTA)...
June 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29757062/the-effect-of-0-5-timolol-maleate-on-corneal-lymph-angiogenesis-in-a-murine-suture-model
#16
Yang Kyung Cho, Eun Young Shin, Hironori Uehara, Balamurali Ambati
PURPOSE: To investigate the anti(lymph)angiogenic and anti-inflammatory effects of 0.5% timolol maleate in a murine corneal suture model. METHODS: Corneal neovascularization and lymphangiogenesis were compared in groups of mice that underwent corneal suture and were subsequently administered a subconjunctival injection of 0.5% timolol maleate, dexamethasone, or phosphate-buffered saline (PBS). Immunohistochemical staining and analysis were performed in each group...
June 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29742011/eyes-on-new-product-development
#17
Gary D Novack
No abstract text is available yet for this article.
June 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29715053/a-review-of-myopia-control-with-atropine
#18
Huy D M Tran, Yen H Tran, Tuan D Tran, Monica Jong, Minas Coroneo, Padmaja Sankaridurg
Myopia is a global public health issue with a worldwide prevalence of ∼30% and is estimated to rise to 50% by 2050. In addition to the burden associated with routine management of the condition, high myopia predisposes the eye to sight-threatening complications such as myopic maculopathy and glaucoma in adult life. Controlling onset and progression of myopia at a young age can reduce the risk of morbidity associated with high myopia. Progression of myopia can be slowed with various optical, environmental, and pharmaceutical strategies, of which atropine has proven to be the most effective...
June 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29608399/eyes-on-new-product-development-preclinical-research
#19
Gary D Novack
No abstract text is available yet for this article.
May 2018: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/29493395/comparison-of-the-clinical-efficacy-of-topical-and-systemic-azithromycin-treatment-for-posterior-blepharitis
#20
Elvin Yildiz, Nursal Melda Yenerel, Ayca Turan-Yardimci, Murat Erkan, Pembegul Gunes
PURPOSE: To compare the clinical efficacy of topical and oral azithromycin treatments for posterior blepharitis. METHODS: Both topical and oral treatment groups comprised 15 patients. In the topical group, azithromycin 15 mg/g ophthalmic solution (Azyter; Thea Pharmaceuticals, Clermont-Ferrand, France) was used twice a day for 3 days and then once a day until the treatment completes a month. In the systemic treatment group, azithromycin 250 mg tablets (Azitro; Deva Pharmaceuticals, Istanbul, Turkey) were used, 1 × 2 tablets (500 mg) at the first day of treatment and then 1 × 1 tablet (250 mg) for 4 days...
May 2018: Journal of Ocular Pharmacology and Therapeutics
journal
journal
32321
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"